Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.44M Buy
4,087
+126
+3% +$44.9K 0.04% 99
2025
Q4
$1.3M Buy
3,961
+30
+0.8% +$9.52K 0.03% 99
2025
Q3
$1.11M Buy
3,931
+33
+0.8% +$9.57K 0.03% 108
2025
Q2
$1.09M Buy
3,898
+215
+6% +$60.9K 0.02% 119
2025
Q1
$1.15M Buy
3,683
+28
+0.8% +$8.27K 0.03% 106
2024
Q4
$953K Buy
3,655
+30
+0.8% +$8.9K 0.03% 111
2024
Q3
$1.17M Buy
3,625
+25
+0.7% +$8.18K 0.03% 114
2024
Q2
$1.13M Buy
3,600
+26
+0.7% +$7.64K 0.03% 105
2024
Q1
$1.02M Buy
3,574
+29
+0.8% +$8.49K 0.03% 109
2023
Q4
$1.02M Buy
3,545
+27
+0.8% +$7.36K 0.04% 103
2023
Q3
$945K Sell
3,518
-15
-0.4% -$3.74K 0.03% 105
2023
Q2
$784K Buy
3,533
+78
+2% +$18.1K 0.03% 119
2023
Q1
$835K Buy
3,455
+32
+0.9% +$7.86K 0.03% 112
2022
Q4
$899K Buy
3,423
+23
+0.7% +$6.17K 0.03% 108
2022
Q3
$766K Buy
3,400
+27
+0.8% +$6.54K 0.03% 112
2022
Q2
$821K Buy
3,373
+26
+0.8% +$6.37K 0.03% 117
2022
Q1
$809K Buy
3,347
+27
+0.8% +$6.2K 0.03% 149
2021
Q4
$747K Buy
3,320
+28
+0.9% +$5.91K 0.02% 150
2021
Q3
$700K Buy
3,292
+26
+0.8% +$5.98K 0.02% 153
2021
Q2
$796K Buy
3,266
+24
+0.7% +$5.9K 0.03% 146
2021
Q1
$807K Hold
3,242
0.03% 137
2020
Q4
$745K Hold
3,242
0.03% 133
2020
Q3
$824K Hold
3,242
0.03% 127
2020
Q2
$765K Buy
+3,242
New +$740K 0.03% 120

Other funds holding AMGN

Bollard Group's AMGN Position: Q1 2026 in Review

Bollard Group increased its Amgen (AMGN) stake by 3.2% in Q1 2026, buying an estimated $44.9K and bringing the position to 4,087 shares worth $1.44M. The position accounts for 0.04% of the portfolio, ranked #99.

Bollard Group first reported a position in AMGN in Q2 2020 and has held it in 24 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Bollard Group held 4,087 shares of Amgen worth $1.44M as of Q1 2026.
  • Bollard Group bought 126 Amgen shares in Q1 2026, an estimated $44.9K.
  • Amgen made up 0.04% of Bollard Group's portfolio in Q1 2026, its #99 holding.
  • Bollard Group first reported a position in Amgen in Q2 2020 and has held it in 24 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bollard Group's 13F filing for Q1 2026, filed 14 May 2026.